Table 1.

Four patients treated with PEDs for VBFs.

Case No	Age	Gender	Initial symptoms	Reason for treatment	Pre-procedural medications	Aneurysm Location	Dimensions of aneurysm (mm)	Dimensions of stents (mm)
1	56	Male	Dizziness, nausea, emesis	Persistent TIAs	Aspirin 81 mg and Meclizine	Holobasilar artery and left VB junction	4.5× 3	4× 35
2	67	Male	Slurred speech	Persistent TIAs	Aspirin 81 mg and Plavix 75 mg	Holobasilar artery	10× 35	4.75× 25, 5× 35, 5× 16
3	56	Male	Dizziness, numbness	Persistent TIAs	Aspirin 81 mg and Plavix 75 mg	Holobasilar and right vertebral artery	11.9× 82	4.75× 25 (5), 5× 35 (2), 5× 20
4	72	Male	Leg weakness	Mass effect	Aspirin 81 mg and Plavix 75 mg	Holobasilar and bilateral vertebral arteries	33× 30	4.5× 30 (3)*, 4.5× 35
Case No	Coils	No of PEDs	Occlusion of aneurysm	Post-procedural antiplatelets	Pre-mRS	Post-mRS	Retreatment	Complication
1	no	6	Complete	Aspirin 325 mg and Plavix 75 mg	2	6	Yes	Thrombosis, recurrence, failed construct, ischemia, death
2	no	3	Incomplete	Aspirin 325 mg and Plavix 75 mg	2	4	No	Ischemia, right hemiparesis
3	no	8	Incomplete	Aspirin 325 mg and Plavix 75 mg	2	6	Yes	Mass effect, hemiparesis, recurrence, death
4	yes	1 (3 Neuroform stents)	N/A	N/A	4	6	N/A	Ischemia, death

VB – vertebrobasilar, TIA – transient ischemic attacks, * - Neuroform stent, mRS – modified Rankin Scale.